Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Vector BioPharma and iBET Collaborate to Develop High-throughput Analytical Methods and Scalable Processes for Gene Delivery
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and […]
Gensaic Receives Funding From the CF Foundation to Develop a Gene Therapy for People With Cystic Fibrosis
Gensaic, a company that seeks to reimagine gene therapy, has announced that it has received […]
Novavax Names John C. Jacobs as New President & Chief Executive Officer
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]
Prokarium and Ginkgo Bioworks Announce Partnership to Discover Multiple Targets for RNA Therapeutics and Immuno-oncology
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, and Ginkgo Bioworks, which […]
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences today announced they have entered into a strategic collaboration and licensing […]
Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial to Treat Solid Tumors
Phio Pharmaceuticals has announced their clinical development partner, AgonOx, has received confirmation from the FDA […]
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria
Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug […]
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome, a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]
Pneumagen Appoints James Noble, a Highly Experienced Biotech Leader, as Chairman of its Board of Directors
Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the […]
New Partnership to Boost Research into Vaccines for Cancer
Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more